Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants

Key Facts

• Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday.
• “I think we’re going to submit to FDA a significant progress of data about the need for a fourth dose, and they need to make their own conclusions, of course, and then CDC also.
• • Since then, around 81.4% of the American population five years old or older have received at least one dose of vaccine out of the three cleared in the U.S. from Pfizer, Moderna and Johnson & Johnson, according to the Centers for Disease Control and Prevention.
• He said Pfizer is working on developing a vaccine that prevents infection in addition to preventing hospitalizations and severe cases of the virus, adding that making long-lasting vaccines is also a priority.

Click To Read Full Article